Corporate structure
Board of Directors
Mr. Lorenzo Tallarigo, M.D.
Board Chairman
Dr. Tallarigo has joined Genextra in may 2009 as Chief Executive Officer.
Previously Dr. Tallarigo worked at Eli Lilly since 1985 where he held various positions in areas of clinical research, pharmaceutical product management and marketing and general management, most recently as its president of international operations.
Dr. Tallarigo is a member of the board of trustees for the University of Indianapolis and is a member of the international committee of the Indiana University Foundation.
Dr. Tallarigo received a doctor of medicine degree from the University of Pisa (Italy). Paolo Fundarò
Managing Director
Is in charge of business management and strategy for Tethis as well as the other companies in the Genextra group.
Paolo Fundarò has been Genextra's Chief Financial Officer and General Manager since its inception, in 2004. He is also Chief Executive Officer of three of the four companies that Genextra controls. Before joining Genextra, Paolo was Director of Finance and Strategic Planning for the FASTWEB Group, from 2000 to 2004, where he was responsible also for the initial phases of the its international development. Previously, he acquired a great level of corporate finance experience working for investment banks such as Salomon Smith Barney (now Citigroup) and Donaldson Lufkin & Jenrette (now Credit Suisse First Boston). Olivetti's take-over bid for Telecom Italia and e.Biscom's (now Fastweb) IPO in 2000, are among the major operations Paolo participated to. Paolo Fundarò has Degree in Business Management from University "L.Bocconi" of Milan. Mario Zanone Poma
Matteo Bruno Renzulli
Davide Turco Board of Statutory Auditors Pietro Michele Villa
President Stefano Morri
Michele Dimonte
Eugenio Romita
Alessandro Giuseppe Galli
Board Chairman
Dr. Tallarigo has joined Genextra in may 2009 as Chief Executive Officer.
Previously Dr. Tallarigo worked at Eli Lilly since 1985 where he held various positions in areas of clinical research, pharmaceutical product management and marketing and general management, most recently as its president of international operations.
Dr. Tallarigo is a member of the board of trustees for the University of Indianapolis and is a member of the international committee of the Indiana University Foundation.
Dr. Tallarigo received a doctor of medicine degree from the University of Pisa (Italy). Paolo Fundarò
Managing Director
Is in charge of business management and strategy for Tethis as well as the other companies in the Genextra group.
Paolo Fundarò has been Genextra's Chief Financial Officer and General Manager since its inception, in 2004. He is also Chief Executive Officer of three of the four companies that Genextra controls. Before joining Genextra, Paolo was Director of Finance and Strategic Planning for the FASTWEB Group, from 2000 to 2004, where he was responsible also for the initial phases of the its international development. Previously, he acquired a great level of corporate finance experience working for investment banks such as Salomon Smith Barney (now Citigroup) and Donaldson Lufkin & Jenrette (now Credit Suisse First Boston). Olivetti's take-over bid for Telecom Italia and e.Biscom's (now Fastweb) IPO in 2000, are among the major operations Paolo participated to. Paolo Fundarò has Degree in Business Management from University "L.Bocconi" of Milan. Mario Zanone Poma
Matteo Bruno Renzulli
Davide Turco Board of Statutory Auditors Pietro Michele Villa
President Stefano Morri
Michele Dimonte
Eugenio Romita
Alessandro Giuseppe Galli